{"id":"W4379282862","doi":"10.1200/jco.2023.41.16_suppl.4004","title":"Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Discontinuation; Internal medicine; Adverse effect; Proportional hazards model; Tremelimumab; Oncology; Confidence interval; Gastroenterology; Cancer; Immunotherapy; Ipilimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003334997,0.0005007178,0.0005639395,0.0003807761,0.0002788353,0.0006002483,0.0004690105,0.0003139407,0.001122768],"category_scores_gemma":[0.002163394,0.0002782856,0.002064594,0.0005568502,0.0002493602,0.0005068257,0.0006303894,0.001112277,0.0001358139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004807853,"about_ca_system_score_gemma":0.0006002379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001161209,"about_ca_topic_score_gemma":0.002251308,"domain_scores_codex":[0.9987691,0.0006421819,0.00009928164,0.0001779622,0.000186448,0.0001249987],"domain_scores_gemma":[0.9973685,0.0006714196,0.001264996,0.0001777299,0.0001276491,0.0003895942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1207452,0.001151333,0.8547596,0.0004739455,0.007312843,0.0001753066,0.0001862771,0.001111726,0.001467888,0.00008996945,0.0007424646,0.01178348],"study_design_scores_gemma":[0.004422638,0.0130229,0.9759302,0.00003730204,0.002882124,0.0002475463,0.0001173183,0.001683728,0.0008080411,0.0001177106,0.0007050331,0.00002550699],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978702,0.0007292953,0.0001927742,0.00003869371,0.000009497993,0.000103084,0.000760315,0.000006664706,0.0002893817],"genre_scores_gemma":[0.9986762,0.0001680274,0.0001554589,0.00003805767,0.00001916904,0.0001136548,0.0006890497,0.000002118559,0.0001381418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003334997,"threshold_uncertainty_score":0.01763737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1149912793136986,"score_gpt":0.4508944703931721,"score_spread":0.3359031910794735,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}